Jim Simons Bausch Health Companies Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 909,572 shares of BHC stock, worth $4.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
909,572
Previous 495,172
83.69%
Holding current value
$4.17 Million
Previous $3.99 Million
47.43%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
243MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$159 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$139 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$121 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$107 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$59.5 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.66B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...